Home Page Overall Ranking ROE Ranking P/E Ranking Dividend Yield Capitalization Our eBook Our Book Contact










Isin US1510201049
Ticker CELG
Company CELGENE
Currency $
Price
Aware Investor Index (AII) 0.0574
Recommendation SELL
P/E 122.30
ROE 13.93 %
Capitalization 100,835,776,000 $
Dividend Yield 0.00 %
P/S 10.89
AII Position 531
P/E Position 733
ROE Position 278
Capitalization Position 82
Dividend Yield Position 629
Sales 9,256,000,000 $
10-Year Average Earnings 824,515,000 $
Shares Outstanding 824,900,000
Equity 5,919,000,000 $
Dividend per Share 0 $
Industry Biotechnology
Country United States
CELGENE Investor Relations Web Site http://ir.celgene.com







Sales:

YEAR MONTH AMOUNT
2015 12 9,256,000,000.00 $
2014 12 7,670,400,000.00 $
2013 12 6,493,900,000.00 $

Earnings:

YEAR MONTH AMOUNT
2015 12 1,602,000,000.00 $
2014 12 1,999,900,000.00 $
2013 12 1,449,900,000.00 $
2012 12 1,456,180,000.00 $
2011 12 1,318,150,000.00 $
2010 12 880,512,000.00 $
2009 12 776,747,000.00 $
2008 12 -1,533,653,000.00 $
2007 12 226,433,000.00 $
2006 12 68,981,000.00 $

Equity:

YEAR MONTH AMOUNT
2015 12 5,919,000,000.00 $
2014 12 6,524,800,000.00 $
2013 12 5,589,900,000.00 $
2012 12 5,694,467,000.00 $
2011 12 5,512,727,000.00 $

Shares Outstanding:

YEAR MONTH AMOUNT
2015 12 824,900,000
2014 12 836,000,000
2013 12 430,300,000
2012 12 440,796,000
2011 12 422,987,284

 












Bloomberg News for CELGENE:

Aug 4, 2010
Arbitrage Profit in U.S. Takeovers Pending on Aug. 4
08/25/10 ARG US APD US 63.50 65.30 -1.80 -2.76 77,416 Cash 08/13/10 ABII US CELG US 72.75 75.78 -3.03 -3.99 2,776 C&S 12/31/10 CASY US ATD/B CN 36.75 ...
Feb 10, 2012
Nasdaq Short Interest as of Jan. 31
642 5,536 CECE CECO ENVIRONMNTL 6,147 7,504 31,975 CELG CELGENE CORP 7,920,994 9,159,230 3,595,048 CELGZ CELGENE CORP-CVR...
Jan 7, 2011
S&P 500 Stocks With Biggest Gap Between Market Price, Estimate
46.18 55.88 -2.48 JPM JPMORGAN CHASE 20.8 22 43.28 52.30 1.77 CELG CELGENE CORP 20.8 22 59.34 71.68 4.61 CSCO CISCO SYSTEMS 20...
Jun 12, 2013
EPS in the First Quarter of ’13 for S&P 500 Stocks by Industry
8.3 Mar 4/25 BIIB Biogen Idec Inc 1.97 1.40 40.7 1.63 20.9 Mar 4/25 CELG Celgene Corp 1.37 1.08 26.9 1.35 1.5 Mar 4/24 LLY Eli Lilly & Co ...
Jun 12, 2013
Positive EPS Surprises for First Quarter of ’13 for S&P 500
63 1.6 Mar 4/26 ABBV AbbVie Inc. 0.68 0.56 21.4 0.67 1.5 Mar 4/25 CELG Celgene Corp 1.37 1.08 26.9 1.35 1.5 Mar 4/18 BBT BB&T Corp ...
Jun 12, 2013
EPS in the First Quarter of ’13 for S&P 500 Stocks by Sectors
14.6 Mar 5/2 CAH Cardinal Health Inc 1.20 0.94 27.7 0.96 25.0 Mar 4/25 CELG Celgene Corp 1.37 1.08 26.9 1.35 1.5 Mar 4/24 WLP WellPoint Inc ...
Nov 14, 2012
Eletrobras Is Worst Power Bet as Rates Decline: Corporate Brazil
before. In 2003, the company rescued Cia. Energetica do Maranhao and is in talks to take over Cia Celg de Participacoes SA, a distributor in Goias state. Government intervention makes Eletrobras a...
Nov 8, 2011
Edgewood Management Holdings in 3rd Quarter: 13F Alert
(USD $) Position In Position Celgene Corp CELG US 390,633,713 6,309,703 -881,339 Visa Inc-Class A Shares V US 373,995...
Jan 24, 2012
Implied Stock-Price Moves for U.S. Companies Reporting Results
46 1.31 01/26 Aft-mkt SBUX* STARBUCKS CORP 3.39 2.60 1.30 01/26 CELG* CELGENE CORP 2.35 1.93 1.22 REPORT TICKER IMPLIED...
Jul 28, 2011
Midmorning Positive EPS Surprises for U.S. Companies, July 28
8.5 0.49 4.1 Jun DRE DUKE REALTY CORP 0.29 0.29 0.0 0.28 3.6 Jun CELG* CELGENE CORP 0.89 0.69 29.0 0.86 3.5 Jun K* KELLOGG CO ...


Google News for CELGENE:

Seeking Alpha - 2 days ago
Celgene: I Don't Necessarily Understand The Science, But I Love ...
Celgene (NASDAQ:CELG) is a premier biotechnology company. It is a quintessential example of a pure growth stock. The company has strung ...
TheStreet.com - 3 days ago
Celgene Is Headed Much Higher Even After a Monster Breakout
This index is now trading at new 2017 highs with the help of an aggressive buying wave. Celgene Corp. (CELG) , the largest holding in the IBB ...
Investor's Business Daily - 3 days ago
Nasdaq Rises; Is Celgene Back From A Two-Year Slump?
... Pharmaceuticals (REGN) rose 6%; Incyte (INCY), 5%; BioMarin Pharmaceutical (BMRN), 4%; Biogen (BIIB), 3.5%; and Celgene (CELG), 3%.
Zacks.com - 15 Jun 2017
Celgene (CELG) Reports Data on Lupus Drug in Phase II Trial
Celgene Corporation (CELG - Free Report) announced results from the phase II trial, SLE-001 at the Annual European Congress of ...
Motley Fool
Spectrum Pharma's Folotyn and Celgene's Istodax combo shows ...
Spectrum Pharma's Folotyn and Celgene's Istodax combo shows ... (pralatrexate) and Celgene's (CELG +1.8%) ISTODAX (romidepsin) in ...
StockNewsJournal
Celgene outperforms after upgrade
Biotech is lower on the session, but not Celgene (CELG +1.6%) after the team at Leerink Swann upgrades to Outperform. A cheap valuation ...
Weekly Register
After Celgene, Regeneron Breakouts, This Biotech Stock May Be Next
With biotech stocks like Celgene (CELG), Bluebird Bio (BLUE), Regeneron (REGN) and Biogen (BIIB) spinoff Bioverativ (BIVV) on the move, ...
Seeking Alpha - 5 days ago
Celgene (CELG) Down 6% Since Earnings Report: Can It Rebound?
It has been about a month since the last earnings report for Celgene Corporation CELG. Shares have lost about 6% in that time frame, ...
Seeking Alpha - 16 Jun 2017
Investors are upbeat on the prospect of these stock's: Celgene ...
Celgene Corporation (NASDAQ:CELG) market capitalization at present is $98.33B at the rate of $126.22 a share. The firm's price-to-sales ratio ...
Barron's
Celgene (CELG) Says Data Evaluating Broad Range of Blood ...
Celgene Corporation (NASDAQ: CELG) today announced that data from a broad range of company-sponsored and investigator-initiated ...


Back